Loading clinical trials...
Loading clinical trials...
This open-label extension trial will assess the long-term use of Lacosamide monotherapy and safety of Lacosamide monotherapy and adjunctive therapy in subjects with partial-onset seizures who were pre...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
UCB Pharma
NCT06608966 · Epilepsy in Children, Executive Dysfunction
NCT06455384 · Cardiac Conditions, Connective Tissue Diseases, and more
NCT05140265 · Epilepsy, Status Epilepticus, and more
NCT06059157 · Drug Resistant Epilepsy
NCT07116421 · Epilepsy, Sudden Unexpected Death in Epilepsy
048
Alabaster, Alabama
010
Birmingham, Alabama
042
Northport, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions